Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension

Takuya Kishi, Yoshitaka Hirooka, Satomi Konno, Kenji Sunagawa

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

N-type calcium channel blocker, cilnidipine, is reported not to increase the heart rate in spite of the strong depressor effect. However, it has not been determined whether cilnidipine has the sympatho-inhibitory effects or not. Moreover, the effect of cilnidipine on the baroreflex control has not been determined. The aim of this study was to determine the effect of cilnidipine on sympathetic and parasympathetic nerve activity, and baroreflex sensitivity. We studied five hypertensive patients treated with 10 mg cilnidipine (10-mg group) and five hypertensive patients treated with 20 mg cilnidipine (20-mg group). Before the treatment and 6 months after the treatment, we measured the blood pressure, spontaneous baroreflex sensitivity (BRS), heart rate variability (HRV), and blood pressure variability (BPV). After 6 months, systolic blood pressure (SBP) and the low-frequency component of systolic BPV expressed in normalized units (LFnuSBP), as the parameter of sympathetic nerve activity, was significantly decreased in both groups, and the suppressive effects were stronger in the 20-mg group than in the 10-mg group. The high-frequency component of HRV expressed in normalized units, as the parameter of parasympathetic nerve activity, and BRS were significantly increased in 20-mg group, but not significant in 10-mg group. These results suggest that 6 months treatment with cilnidipine for hypertension has the sympatho-inhibtory effect, and that high-dose cilnidipine improves the parasympathetic nerve activity and baroreflex control in patients with hypertension.

Original languageEnglish
Pages (from-to)241-249
Number of pages9
JournalClinical and Experimental Hypertension
Volume31
Issue number3
DOIs
Publication statusPublished - May 1 2009

Fingerprint

Baroreflex
Hypertension
Blood Pressure
Heart Rate
N-Type Calcium Channels
cilnidipine
Calcium Channel Blockers
Therapeutics

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology

Cite this

Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension. / Kishi, Takuya; Hirooka, Yoshitaka; Konno, Satomi; Sunagawa, Kenji.

In: Clinical and Experimental Hypertension, Vol. 31, No. 3, 01.05.2009, p. 241-249.

Research output: Contribution to journalArticle

Kishi, Takuya ; Hirooka, Yoshitaka ; Konno, Satomi ; Sunagawa, Kenji. / Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension. In: Clinical and Experimental Hypertension. 2009 ; Vol. 31, No. 3. pp. 241-249.
@article{9115d84af7ae49c1aa03e07001cf389f,
title = "Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension",
abstract = "N-type calcium channel blocker, cilnidipine, is reported not to increase the heart rate in spite of the strong depressor effect. However, it has not been determined whether cilnidipine has the sympatho-inhibitory effects or not. Moreover, the effect of cilnidipine on the baroreflex control has not been determined. The aim of this study was to determine the effect of cilnidipine on sympathetic and parasympathetic nerve activity, and baroreflex sensitivity. We studied five hypertensive patients treated with 10 mg cilnidipine (10-mg group) and five hypertensive patients treated with 20 mg cilnidipine (20-mg group). Before the treatment and 6 months after the treatment, we measured the blood pressure, spontaneous baroreflex sensitivity (BRS), heart rate variability (HRV), and blood pressure variability (BPV). After 6 months, systolic blood pressure (SBP) and the low-frequency component of systolic BPV expressed in normalized units (LFnuSBP), as the parameter of sympathetic nerve activity, was significantly decreased in both groups, and the suppressive effects were stronger in the 20-mg group than in the 10-mg group. The high-frequency component of HRV expressed in normalized units, as the parameter of parasympathetic nerve activity, and BRS were significantly increased in 20-mg group, but not significant in 10-mg group. These results suggest that 6 months treatment with cilnidipine for hypertension has the sympatho-inhibtory effect, and that high-dose cilnidipine improves the parasympathetic nerve activity and baroreflex control in patients with hypertension.",
author = "Takuya Kishi and Yoshitaka Hirooka and Satomi Konno and Kenji Sunagawa",
year = "2009",
month = "5",
day = "1",
doi = "10.1080/10641960902822492",
language = "English",
volume = "31",
pages = "241--249",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension

AU - Kishi, Takuya

AU - Hirooka, Yoshitaka

AU - Konno, Satomi

AU - Sunagawa, Kenji

PY - 2009/5/1

Y1 - 2009/5/1

N2 - N-type calcium channel blocker, cilnidipine, is reported not to increase the heart rate in spite of the strong depressor effect. However, it has not been determined whether cilnidipine has the sympatho-inhibitory effects or not. Moreover, the effect of cilnidipine on the baroreflex control has not been determined. The aim of this study was to determine the effect of cilnidipine on sympathetic and parasympathetic nerve activity, and baroreflex sensitivity. We studied five hypertensive patients treated with 10 mg cilnidipine (10-mg group) and five hypertensive patients treated with 20 mg cilnidipine (20-mg group). Before the treatment and 6 months after the treatment, we measured the blood pressure, spontaneous baroreflex sensitivity (BRS), heart rate variability (HRV), and blood pressure variability (BPV). After 6 months, systolic blood pressure (SBP) and the low-frequency component of systolic BPV expressed in normalized units (LFnuSBP), as the parameter of sympathetic nerve activity, was significantly decreased in both groups, and the suppressive effects were stronger in the 20-mg group than in the 10-mg group. The high-frequency component of HRV expressed in normalized units, as the parameter of parasympathetic nerve activity, and BRS were significantly increased in 20-mg group, but not significant in 10-mg group. These results suggest that 6 months treatment with cilnidipine for hypertension has the sympatho-inhibtory effect, and that high-dose cilnidipine improves the parasympathetic nerve activity and baroreflex control in patients with hypertension.

AB - N-type calcium channel blocker, cilnidipine, is reported not to increase the heart rate in spite of the strong depressor effect. However, it has not been determined whether cilnidipine has the sympatho-inhibitory effects or not. Moreover, the effect of cilnidipine on the baroreflex control has not been determined. The aim of this study was to determine the effect of cilnidipine on sympathetic and parasympathetic nerve activity, and baroreflex sensitivity. We studied five hypertensive patients treated with 10 mg cilnidipine (10-mg group) and five hypertensive patients treated with 20 mg cilnidipine (20-mg group). Before the treatment and 6 months after the treatment, we measured the blood pressure, spontaneous baroreflex sensitivity (BRS), heart rate variability (HRV), and blood pressure variability (BPV). After 6 months, systolic blood pressure (SBP) and the low-frequency component of systolic BPV expressed in normalized units (LFnuSBP), as the parameter of sympathetic nerve activity, was significantly decreased in both groups, and the suppressive effects were stronger in the 20-mg group than in the 10-mg group. The high-frequency component of HRV expressed in normalized units, as the parameter of parasympathetic nerve activity, and BRS were significantly increased in 20-mg group, but not significant in 10-mg group. These results suggest that 6 months treatment with cilnidipine for hypertension has the sympatho-inhibtory effect, and that high-dose cilnidipine improves the parasympathetic nerve activity and baroreflex control in patients with hypertension.

UR - http://www.scopus.com/inward/record.url?scp=67649997687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649997687&partnerID=8YFLogxK

U2 - 10.1080/10641960902822492

DO - 10.1080/10641960902822492

M3 - Article

C2 - 19387900

AN - SCOPUS:67649997687

VL - 31

SP - 241

EP - 249

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 3

ER -